Ryvis Pharma is a 100% Canadian owned pharmaceutical company with a global presence. Ryvis Pharma is a leader in key international markets regarding the development, production, distribution, and marketing of pharmaceutical, OTC, and veterinary products. Here at Ryvis Pharma, the focus is on making the highest quality products at affordable prices. Over two decades ago, the company entered the pharmaceutical industry and has since become a leader in globally competitive high-quality FDA approved products. The commitment to high-quality products and affordable pricing reflects in the business philosophy: “Right Quality at Right Price.” Together, with partners and customers, Ryvis Pharma executes its vision to provide quality and affordable healthcare in countries all over the world. The company operates in the Manufacturing and Pharmaceutical industries, aiming to address the global need for accessible healthcare products. With a strong emphasis on international markets, Ryvis Pharma presents an opportunity for venture capitalists to engage with a company that has a solid track record and a clear mission.
There is no investment information
No recent news or press coverage available for Ryvis Pharma.